IRadimed Corporation
IRMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $697 | $598 | $355 | $571 |
| - Cash | $52 | $50 | $58 | $62 |
| + Debt | $0 | $2 | $2 | $2 |
| Enterprise Value | $645 | $551 | $300 | $511 |
| Revenue | $73 | $66 | $53 | $42 |
| % Growth | 11.7% | 23% | 27.5% | – |
| Gross Profit | $56 | $50 | $41 | $32 |
| % Margin | 76.9% | 76.5% | 77.4% | 76.6% |
| EBITDA | $23 | $21 | $16 | $11 |
| % Margin | 31.1% | 31.7% | 30.6% | 26.8% |
| Net Income | $19 | $17 | $13 | $9 |
| % Margin | 26.3% | 26.2% | 24.1% | 22.3% |
| EPS Diluted | 1.5 | 1.35 | 1.02 | 0.74 |
| % Growth | 11.1% | 32.4% | 37.8% | – |
| Operating Cash Flow | $26 | $13 | $10 | $11 |
| Capital Expenditures | -$8 | -$8 | -$2 | -$1 |
| Free Cash Flow | $18 | $5 | $8 | $11 |